On the public citation graph

Pharmaceutical pricing dynamics in an internal reference pricing system: evidence from changing drugs’ reimbursements

https://doi.org/10.1007/s10198-022-01440-2
0 signed · 27 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/hec.1103openalex-snapshot
A re‐examination of the impact of reference pricing on anti‐hypertensive drug plan expenditures in British Columbia
inferredcites →https://doi.org/10.1002/hec.3068openalex-snapshot
THE WELFARE IMPACT OF PARALLEL IMPORTS: A STRUCTURAL APPROACH APPLIED TO THE GERMAN MARKET FOR ORAL ANTI‐DIABETICS
inferredcites →https://doi.org/10.1002/hec.3801openalex-snapshot
Price elasticities of pharmaceuticals in a value based‐formulary setting
inferredcites →https://doi.org/10.1007/s10198-009-0172-3openalex-snapshot
The impact of reference pricing on switching behaviour and healthcare utilisation: the case of statins in Germany
inferredcites →https://doi.org/10.1007/s10198-012-0442-3openalex-snapshot
The impact of generic reference pricing in Italy, a decade on
inferredcites →https://doi.org/10.1007/s11151-009-9214-3openalex-snapshot
Generic Entry into the Regulated Spanish Pharmaceutical Market
inferredcites →https://doi.org/10.1016/j.euroecorev.2008.03.004openalex-snapshot
Regulation and pricing of pharmaceuticals: Reference pricing or price cap regulation?
inferredcites →https://doi.org/10.1016/j.healthpol.2007.02.010openalex-snapshot
The impact of generic reference pricing interventions in the statin market
inferredcites →https://doi.org/10.1016/j.ijindorg.2013.10.005openalex-snapshot
Pharmaceutical followers
inferredcites →https://doi.org/10.1016/j.jhealeco.2006.11.003openalex-snapshot
Reference pricing of pharmaceuticals
inferredcites →https://doi.org/10.1016/j.jhealeco.2008.09.006openalex-snapshot
Reference pricing and firms’ pricing strategies
inferredcites →https://doi.org/10.1016/j.jhealeco.2014.04.003openalex-snapshot
Regulation of pharmaceutical prices: Evidence from a reference price reform in Denmark
inferredcites →https://doi.org/10.1016/j.jhealeco.2016.04.003openalex-snapshot
Reference pricing with endogenous generic entry
inferredcites →https://doi.org/10.1016/j.jhealeco.2017.08.008openalex-snapshot
Tiered co-payments, pricing, and demand in reference price markets for pharmaceuticals
inferredcites →https://doi.org/10.1016/j.jhealeco.2018.06.009openalex-snapshot
Price competition in pharmaceuticals – Evidence from 1303 Swedish markets
inferredcites →https://doi.org/10.1016/j.jpubeco.2010.11.015openalex-snapshot
Reference pricing, competition, and pharmaceutical expenditures: Theory and evidence from a natural experiment
inferredcites →https://doi.org/10.1016/s0168-8510(00)00100-7openalex-snapshot
Review of the literature on reference pricing
inferredcites →https://doi.org/10.1377/hlthaff.28.2.546openalex-snapshot
Patients’ Perceptions Of Generic Medications
inferredcites →https://doi.org/10.2139/ssrn.2617267openalex-snapshot
Does Reference Pricing Drive Out Generic Competition in Pharmaceutical Markets? Evidence from a Policy Reform.
inferredcites →https://doi.org/10.2165/00148365-200504020-00003openalex-snapshot
What is Required to Evaluate the Impact of Pharmaceutical Reference Pricing?
inferredcites →https://doi.org/10.2165/11537860-000000000-00000openalex-snapshot
Effects of Reference Pricing in Pharmaceutical Markets
inferredcites →https://doi.org/10.2307/2555818openalex-snapshot
The Importance of the Physician in the Generic versus Trade-Name Prescription Decision
inferredcites →https://doi.org/10.2307/3087468openalex-snapshot
Do Pharmaceutical Prices Respond to Potential Patient Out-of-Pocket Expenses?

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4573276openalex-extracted
Multimarket Competition and Pharmaceutical Firms’ Exit Decisions
inferred← citeshttps://doi.org/10.1002/hec.70029openalex-snapshot
The Impact of Multimarket Competition on Generic Drugs' Regulated Prices
inferred← citeshttps://doi.org/10.1007/s43546-025-00809-8openalex-snapshot
Advertising increases demand for the equivalent drugs: a theoretical model
inferred← citeshttps://doi.org/10.1186/s40545-022-00451-xopenalex-snapshot
Indication-wide drug pricing: Insights from the pharma market
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.